Cullinan Therapeutics, Inc.
CGEMNasdaqCIK 1789972HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0223:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-411011 |
| 2026-09-2411:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-400144 |
| 2026-09-1411:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-389844 |
| 2026-08-1323:35 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-347400 |
| 2026-08-0611:10 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336717 |
| 2026-08-0611:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336700 |
| 2026-06-1621:18 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-272890 |
| 2026-06-1011:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-264916 |
| 2026-06-0810:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-260640 |
| 2026-05-1821:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-229173 |
| 2026-05-0711:08 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210304 |
| 2026-05-0711:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210290 |
| 2026-04-2810:50 ET | DEF 14A | Proxy statementPeriod 2026-04-27 | 0001193125-26-183465 |
| 2026-03-1011:26 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-099362 |
| 2026-03-1011:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-099355 |
| 2026-01-0812:15 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-006998 |
| 2025-12-0815:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-310764 |
| 2025-11-2121:30 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-25-291448 |
| 2025-11-0612:13 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268066 |
| 2025-11-0612:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-268041 |
| 2025-11-0314:14 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-261799 |
| 2025-09-0410:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-112949 |
| 2025-08-0711:07 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104551 |
| 2025-08-0711:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-104547 |
| 2025-06-1220:23 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-085425 |
| 2025-06-0420:04 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081601 |
| 2025-05-0811:24 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066384 |
| 2025-05-0811:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066382 |
| 2025-04-2510:56 ET | DEF 14A | Proxy statementPeriod 2025-04-24 | 0000950170-25-058316 |
| 2025-02-2712:07 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-028346 |
| 2025-02-2712:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028343 |
| 2025-01-2912:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-010199 |
| 2024-11-0712:18 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122795 |
| 2024-11-0712:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122778 |
| 2024-10-1611:17 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-114841 |
| 2024-09-1711:13 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-107011 |
| 2024-08-0811:20 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093320 |
| 2024-08-0811:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093314 |
| 2024-06-2721:00 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-078554 |
| 2024-06-0312:12 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-067662 |
| 2024-05-2321:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-064025 |
| 2024-05-1610:40 ET | DEF 14A | Proxy statementPeriod 2024-06-26 | 0001193125-24-139976 |
| 2024-05-1520:31 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-060535 |
| 2024-05-1520:15 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-060481 |
| 2024-04-2911:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-049436 |
| 2024-04-1611:14 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-044593 |
| 2024-03-1411:22 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-031143 |
| 2024-03-1411:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-031140 |
| 2024-01-0821:15 ET | 8-K/A | 2.02 Results of operations | 0000950170-24-002936 |
| 2024-01-0814:12 ET | 8-K | 2.01 Completion of an acquisition or disposition | 0000950170-24-002745 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.